Kumamoto, Japan

Kohichi Kawahara

This inventor holds 1 USPTO granted patent. Top assignee: Kemphys Ltd.. Active years: 2018.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Kohichi Kawahara. Retrieved from https://idiyas.com/inventor/kohichi-kawahara

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2018

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Kohichi Kawahara: Innovator in Alzheimer's Disease Treatment

Introduction

Kohichi Kawahara is a notable inventor based in Kumamoto, Japan. He has made significant contributions to the field of medicine, particularly in the treatment of Alzheimer's disease. His innovative approach combines various therapeutic agents to address this challenging condition.

Latest Patents

Kawahara holds a patent for a medicament aimed at the therapeutic and preventive treatment of Alzheimer's disease. This medicament comprises a combination of a retinoic acid receptor (RAR) agonist, such as Am80, and a retinoid X receptor (RXR) agonist, such as HX630. This unique formulation represents a promising advancement in the fight against Alzheimer's disease.

Career Highlights

Throughout his career, Kawahara has focused on developing effective treatments for neurodegenerative diseases. His work has garnered attention for its potential to improve the quality of life for patients suffering from Alzheimer's disease. He is associated with Kemphys Ltd., where he continues to innovate in the field of medicinal chemistry.

Collaborations

Kawahara has collaborated with esteemed colleagues, including Michita Suenobu and Koichi Shudo. These partnerships have facilitated the exchange of ideas and expertise, further enhancing the development of effective treatments.

Conclusion

Kohichi Kawahara's contributions to Alzheimer's disease treatment through his innovative patent highlight his dedication to improving patient outcomes. His work exemplifies the importance of collaboration and innovation in the medical field.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…